When Fatigue Isn’t Just Tiredness In the outpatient clinic, it’s not uncommon to meet young women who’ve been living with ...

Description Due to oral bleeding, a 34-year-old male patient was admitted to the hospital. Additionally, he developed hematochezia as a result of an anal fissure brought on by a hard stool. In the ...

Inspired by her own mother's battle, Dr. Lauren Powell is on a mission to improve care for lupus patients of all backgrounds.

Dr. Freedman, whose expertise is related to diseases involving the mouth, including autoimmune processes, presented a lecture on the effects of lupus and oral health. He began by informing the ...

These activities will increase saliva production and thus reduce discomfort from dry mouth. Finally, Dr. Lockshin spoke about some new agents for lupus and RA that are in development. As with ...

This mysterious autoimmune disease presents with over 100 different symptoms, making diagnosis incredibly challenging for ...

Objectives While diffuse alveolar haemorrhage (DAH) is recognised as a life-threatening complication of systemic lupus erythematosus (SLE), little is known about its risk factors and response to ...

What makes love after lupus different is that it requires that one be willing to adapt to the challenges of this chronic ...

“We are pleased to present at LUPUS 2025 the first reported Phase 1 results for a cGAS inhibitor, demonstrating that VENT-03 has the potential to become a first- and best-in-class therapy for ...

Merck, a leading science and technology company, today announced positive data on enpatoran, an investigational, oral, novel TLR7/8 inhibitor, demonstrating clinically meaningful reduction in disease ...

SLE flares continue to occur after ESKD in a substantial subset of patients, warranting closer monitoring. Extrarenal lupus flares continue to occur in more than one-third of patients with end-stage ...

This study is being conducted to evaluate the safety, tolerability, and ability to manufacture Descartes-08, an investigational mRNA CAR-T cell therapy, in people living with moderate to severe ...